FDA Inspection
BSP Pharmaceuticals SpABSP Pharmaceuticals SpA – FDA Inspection, Nov 12, 2021
Record Details
This FDA Inspection record concerns BSP Pharmaceuticals SpA, with an inspection on November 12, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- BSP Pharmaceuticals SpA
- Inspection Date
- November 12, 2021
- Product Type
- Drugs
View Company Profile
ID · ab1fa615-f7d5-446f-8627-7b386db151d7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1172555
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of BSP Pharmaceuticals SpA
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 29, 2024 | Not classified | Office of Inspections and Investigations | |
| September 21, 2018 | Not classified | Office of Inspections and Investigations | |
| October 20, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 26, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BSP Pharmaceuticals SpA
- FDA Inspection 1232171 - 2024-02-29
- FDA Inspection 1071722 - 2018-09-21
- FDA Inspection 1091112 - 2017-10-20
- FDA Inspection 1016102 - 2016-12-16
- FDA Inspection 935609 - 2015-06-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.